Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors - PubMed (original) (raw)
. 1996 May 10;271(19):11376-82.
doi: 10.1074/jbc.271.19.11376.
Affiliations
- PMID: 8626692
- DOI: 10.1074/jbc.271.19.11376
Free article
Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
J Arribas et al. J Biol Chem. 1996.
Free article
Abstract
The extracellular domains of a diverse group of membrane proteins are shed in response to protein kinase C activators such as phorbol 12-myristate 13-acetate (PMA). The lack of sequence similarity in the cleavage sites suggests the involvement of many proteases of diverse specificity in this process. However, a mutant Chinese hamster ovary cell line recently isolated for being defective in PMA-activated shedding of the membrane-anchored growth factor transforming growth factor alpha precursor (proTGF-alpha) is concomitantly defective in the shedding of many other unrelated membrane proteins. Here we show that independent mutagenesis and selection experiments yield shedding mutants having the same recessive phenotype and belonging to the same genetic complementation group. Furthermore, two structurally distinct agents, TAPI-2 and 1,10-phenanthroline, which are known to inhibit metalloproteases, block PMA-activated shedding of proTGF-alpha, cell adhesion receptor L-selectin, interleukin 6 receptor alpha subunit, beta-amyloid precursor protein, and an entire set of anonymous Chinese hamster ovary cell surface proteins. Certain serine protease inhibitors prevent release of these proteins by interfering with their maturation and transport to the cell surface but do not inhibit ectodomain shedding from the cell surface. The results suggest the existence of a common system for membrane protein ectodomain shedding involving one or several proteolytic activities sensitive to metalloprotease inhibitors, whose ability to act can be disrupted by recessive mutations in a single gene.
Similar articles
- A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor.
Müllberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, Black RA, Mohler KM. Müllberg J, et al. J Immunol. 1995 Dec 1;155(11):5198-205. J Immunol. 1995. PMID: 7594530 - Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding.
Arribas J, López-Casillas F, Massagué J. Arribas J, et al. J Biol Chem. 1997 Jul 4;272(27):17160-5. doi: 10.1074/jbc.272.27.17160. J Biol Chem. 1997. PMID: 9202036 - Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme.
Merlos-Suárez A, Ruiz-Paz S, Baselga J, Arribas J. Merlos-Suárez A, et al. J Biol Chem. 2001 Dec 21;276(51):48510-7. doi: 10.1074/jbc.M103488200. Epub 2001 Oct 12. J Biol Chem. 2001. PMID: 11600492 - Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.
Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD. Ludwig A, et al. Comb Chem High Throughput Screen. 2005 Mar;8(2):161-71. doi: 10.2174/1386207053258488. Comb Chem High Throughput Screen. 2005. PMID: 15777180 Review. - Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding.
Blobel CP. Blobel CP. Inflamm Res. 2002 Feb;51(2):83-4. doi: 10.1007/BF02684007. Inflamm Res. 2002. PMID: 11926318 Review.
Cited by
- Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy.
Franke AK, Wessolowski C, Thaden V, Müller I, Cornils K. Franke AK, et al. Gene Ther. 2023 Aug;30(7-8):603-611. doi: 10.1038/s41434-022-00374-x. Epub 2022 Dec 19. Gene Ther. 2023. PMID: 36529796 Free PMC article. - Angiotensin converting enzyme 2 is a novel target of the γ-secretase complex.
Bartolomé A, Liang J, Wang P, Ho DD, Pajvani UB. Bartolomé A, et al. Sci Rep. 2021 May 7;11(1):9803. doi: 10.1038/s41598-021-89379-x. Sci Rep. 2021. PMID: 33963249 Free PMC article. - Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process.
Süntar I, Çetinkaya S, Panieri E, Saha S, Buttari B, Profumo E, Saso L. Süntar I, et al. Molecules. 2021 Apr 21;26(9):2424. doi: 10.3390/molecules26092424. Molecules. 2021. PMID: 33919399 Free PMC article. Review. - Constitutive and Regulated Shedding of Soluble FGF Receptors Releases Biologically Active Inhibitors of FGF-2.
Hanneken A, Mercado M, Maher P. Hanneken A, et al. Int J Mol Sci. 2021 Mar 8;22(5):2712. doi: 10.3390/ijms22052712. Int J Mol Sci. 2021. PMID: 33800200 Free PMC article. - The transmembrane protein LRIG1 triggers melanocytic tumor development following chemically induced skin carcinogenesis.
Hoesl C, Fröhlich T, Posch C, Kneitz H, Goebeler M, Schneider MR, Dahlhoff M. Hoesl C, et al. Mol Oncol. 2021 Aug;15(8):2140-2155. doi: 10.1002/1878-0261.12945. Epub 2021 Mar 31. Mol Oncol. 2021. PMID: 33786987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials